BALTIMORE, MD. (PRWEB) OCTOBER 11, 2017
Proscia Inc., a data solutions provider for digital pathology, announced today it will be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing Director of Advanced Pathology Associates, on digital pathology adoption best practices and how Proscia improves lab economics and realizes an increase in diagnostic confidence.*
A live webcast from Dr. Cacciabeve’s lab will take place on Thursday, October 19, 2017 at 4:00 p.m. EDT. To join the liver webinar event, please register via Proscia’s website: https://proscia.com/webinar.
“Proscia’s new clinical solutions give us the flexibility to adopt digital pathology in phases and set us on a course to incorporate Proscia’s AI-based computational pathology applications,” said Dr. Nicolas Cacciabeve, Managing Director of Advanced Pathology Associates, a 15-pathologist independent practice providing service to seven hospitals and an anatomic pathology reference laboratory in the Rockville, Maryland area. “In this webinar, I will walk through how our lab is being transformed by utilizing Proscia’s software and share best practices for adopting digital pathology based on your lab’s needs.”
During the webinar you will hear a Proscia customer speak about adopting digital pathology and how it’s helping transform their lab. Additionally you can:
- Learn how Proscia’s modular software can help you adopt digital pathology at your own pace.
- See some of the powerful clinical applications of Proscia’s platform, including consultation and digital immunohistochemistry (IHC).
- Explore how Proscia drives precision medicine and computational pathology in your lab with machine learning and artificial intelligence (AI) techniques.
“With the recent FDA approval of the first WSI scanner for primary diagnosis, digital pathology adoption is happening at an accelerated pace,” said David West, chief executive officer of Proscia. “Labs are recognizing the broad benefits of going digital, creating exciting opportunities for new revenue streams and broadening the impact that pathology has on cancer diagnosis and research. Proscia’s award-winning software is uniquely positioned in this transition to deliver applications for clinical use-cases and set the stage for AI-based computational pathology.”
*Proscia software is not intended for primary diagnostic use.
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed and quality of pathology diagnostics and research. To learn more, please visit http://www.proscia.com.